Bayer AG, a well-known company in the pharmaceutical and agrochemical industries, has been given a neutral rating by UBS.

The company"s revenue is mainly generated from agrochemicals, accounting for 48.8% of total sales, followed by pharmaceuticals at 38%. The pharmaceutical segment focuses on treating cardiovascular and respiratory diseases, diabetes, and nervous system disorders. In addition, OTC products and nutritional supplements contribute 12.7% to the company"s revenue, while other products make up 0.5%.

Geographically, Bayer has a strong presence in the United States, which represents 30.6% of total sales. Other important markets include Europe-Middle East-Africa at 23.2%, China at 7.6%, and Brazil at 10.4%. The company also generates sales from Germany (5.1%), Switzerland (1.2%), North America (3.5%), Asia-Pacific (10%), and Latin America (8.4%). Bayer"s diverse product portfolio and global market positioning are evident from its sales distribution.